プラチナバイオ株式会社
東広島市, JP · 2 known investors
PtBio develops genome editing technology and bio-DX tools for analyzing the genomes of industrially used organisms, positioning itself as a platform provider. Its applications include allergy-free eggs, CO2-converting microalgae for carbon recycling, advanced medical treatments, resource-recycling agriculture, aquatic resource supply, and bio-manufacturing.
Founders & leadership
KO
Keisuke OkuharaRepresentative Director & CEO
奥啓
奥原 啓輔代表取締役 (Representative Director)
TY
Takashi YamamotoDirector & CTO
AI
Atsuhiro IshiiCOO
HB
Hidemasa BonoCSO (Chief Scientific Officer)
YK
Yumiko KusakabeChief Strategy Officer
Investors · 2
Frequently asked questions
- What does プラチナバイオ株式会社 do?
- PtBio develops genome editing technology and bio-DX tools for analyzing the genomes of industrially used organisms, positioning itself as a platform provider. Its applications include allergy-free eggs, CO2-converting microalgae for carbon recycling, advanced medical treatments, resource-recycling agriculture, aquatic resource supply, and bio-manufacturing.
- Who founded プラチナバイオ株式会社?
- プラチナバイオ株式会社 was founded by Keisuke Okuhara.
- Who are プラチナバイオ株式会社's investors?
- プラチナバイオ株式会社's investors include Hiroshima Venture Capital Co. Ltd., Kobe University Capital.
- Where is プラチナバイオ株式会社 headquartered?
- プラチナバイオ株式会社 is headquartered in 東広島市, JP.